Contract Pharma: 'A Modern CDMO' Article

Quotient Sciences' Head of Drug Substance, Paul Quigley, recently shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO. In his article for Contract Pharma, Paul explains the greater need for more effective process solutions during drug development and how successful contract service organisations are meeting this challenge. He also defines the Quotient Sciences model for accelerated delivery, through integrated services and technological innovation.

Access the article here: